About: http://data.cimple.eu/news-article/d67ea88bc6a89c4277c3c33b48e1b386e127a23c56bcc67042d47c85     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • The French competition authority (AFC) on Thursday slapped a record 444 million euro ($500 million) fine on pharma groups Novartis, Roche and Genentech over market abuses in sales of macular degeneration drugs. The trio were found to have abused dominant market position to sell their Lucentis drug, developed by US firm Genentech and used in the treatment of age-related macular degeneration (AMD), to the detriment of another much cheaper treatment, Avastin. Swiss firm Novartis marketed Lucentis outside the US. But doctors realised that Genentech's anti-cancer drug Avastin could have positive effects on the eye disease and began to prescribe it. Roche, which, since 2009, has a 100 percent capital stake in Genentech, markets Avastin outside of the United States. An injection of Avastin costs around 30 to 40 euros, compared with a launch price of 1,161 euros for Lucentis -- ramping up the cost for French social security, which picks up the full tab for the treatment needed by some 150,000 people in France. The AFC ruled the three firms had collaborated to maximise AMD earnings and make it harder for health authorities to compare the relative cost of Lucentis with that of Avastin. Novartis was hit with the bulk of the fine at 385 million euros, while Roche and Genentech must pay more than 59 million between them. lem-kd-noo/ak/nm/cdw/tgb
schema:headline
  • Record French fine for pharma giants over eye drug
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software